Caricamento...
Liraglutide-Induced Hepatotoxicity
A 52-year-old woman with a BMI of 31.2 kg/m(2) was treated with the glucagon-like peptide 1 (GLP-1) agonist liraglutide as part of her weight-reduction program. Following this, she developed an idiosyncratic drug-related liver injury (IDILI). Advances in noninvasive techniques enabled this diagnosis...
Salvato in:
| Pubblicato in: | Biomedicines |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7911918/ https://ncbi.nlm.nih.gov/pubmed/33498980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9020106 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|